Triple Hair is a Canadian biotechnology company that is developing new topical treatments for men and women who suffer from androgenic alopecia. A number of people have mentioned this company in the comments in recent years.
Triple Hair: Therapy-07 for Hair Growth
Triple Hair’s main product is a prescription triple combination topical called Therapy-07. It contains minoxidil, finasteride and latanoprost (a prostaglandin F2α analog). It is currently sold via Texas-based Pharmacy Solutions.
When I first read about Therapy-07, while it seemed interesting, it did not sound like anything special to me. The reason is because we are now spoiled for choice when it comes to online purchase options of topical finasteride containing hair loss products that also include minoxidil and other key ingredients.
- In fact HairStim (US) already makes a product that contains minoxidil, finasteride and latanoprost. As well as other combinations that include spironolactone and resveratrol.
- Another US-based company named Aneira Pharma is working a product that includes latanoprost, minoxidil and various other ingredients.
Phase 3 Clinical Trial Approvals in Europe and Canada
However, today I changed my mind slightly after reader “John Doe” e-mailed me to notify that Triple Hair has just received EMA approval to start phase III clinical trials for its Therapy-07 prescription drug in Europe.
Do note that in June 2023, Triple Hair already received approval to begin phase III clinical trials in Canada. At the time, company CEO Jean-Philippe Gravel said that they were also awaiting similar approvals in the US and Europe. As soon as all approvals are obtained they planned to begin the final trials.
So far, among the many companies selling topical finasteride for hair loss, only Almirall (Spain) has gone through the entire three stage clinical trial process. The expenses to go through three trials for a topical hair loss porduct is generally not justifiable to investors. Especially with key ingredients such as finasteride and minoxidil.
Therapy-16
Triple Hair also sells an over-the-counter hair loss product called Therapy-16. For men, it is sold via the brand name Rizn. It is a drug-free once a day formula that is made with natural ingredients. They sell a RIZN Hair Density Spray and RIZN Hair Complex pills. The woman’s Therapy-16 Hair Densifying Spray product goes by the brand name Plenty Natural. Is contains Japanese knotweed, melatonin and peasprout extracts.
Interestingly, the company claims that these products reduce Prostaglandin D2 (PGD2) levels, which aid hair growth. I discussed the positive impact of decreasing PGD2 on hair growth in several posts in the past. However, I am skeptical about how big an impact natural products can have on scalp PGD2 levels.
If hair stem already makes a product with the same ingredients and sells them already..why is triple hair spending money doing trials on this….seems counterproductive.
Perhaps they have a better delivery system. Perhaps they use a different dose of Latanoprost.
People will likely trust a product that goes through trials more than so many other ones out there online now.
I didn’t think about it that way, that makes sense.
I had an RX from my derm through Hairstim, wasn’t impressed by their lack of knowledge and transparency. I chose not to use them and had the RX filled through an alternate pharmacy/source (different than my current). Bimatoprost is in one of my current topicals, not sure that it does anything…do no harm and maybe some good!